$A

What Are Wall Street Analysts' Target Price for Agilent Technologies Stock?

Analysts' average price target for Agilent Technologies (A) is $159.21, slightly above current levels. The highest target is $185, suggesting a 16.5% upside. This information is for educational purposes only.

Original reporting
Published Aug 21, 2026, 11:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 22, 2026, 12:20 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
What Are Wall Street Analysts' Target Price for Agilent Technologies Stock? — source image
Decision brief

The 30-second read

$ANeutralLow
01

Why it matters

Provides a snapshot of analyst expectations but no new corporate event.

02

Market read

Analyst target updates are routine and offer limited trading impetus.

03

What to watch

Potential supply‑chain constraints or competitive pressure not reflected in targets.

Relevance 6/10Novelty 5/10Timing: none

Background

The article compiles analyst price targets for Agilent Technologies.

Company-level read

Ticker impact

$ANeutralMedium confidence
Context

Analysts set a mean price target of $159.21 and a high target of $185 for Agilent Technologies, implying ~16.5% upside.

Expected impact

Potential modest price appreciation if targets are incorporated.

Evidence & confidence

Targets are new but represent typical analyst opinion without a catalyst.

Market effects

Limited impact on the broader health‑care equipment sector.

No specific regional effect.

Minimal global relevance.

Counterpoint

Targets may be overly optimistic if upcoming earnings miss expectations.

Key entities

  • Agilent Technologies

    US‑listed provider of life sciences and diagnostics equipment.

Related articles

$AHighAI 8/10

Agilent earnings analysis: questions answered and next catalysts

Agilent reported FY2026 Q3 earnings with EPS of $1.62 (8.7% above consensus) and revenue of $1.88B (2.2% above estimates). This marks the third consecutive quarter of EPS acceleration, with revenue growth of 6.7% in FY2025. However, gross margins slipped to 52.4% and free cash flow declined to $1.15B. The stock trades at 30.9x trailing P/E, with a fair-value estimate of $145.64, suggesting a 7.6% overvaluation.

$AHighAI 8/10

Agilent Technologies Inc (A) (Q3 2026) Earnings Call Highlights: Strong Core Growth

Agilent Technologies reported Q3 2026 earnings, raising guidance but noting a slowdown in core growth to 5.2%-6.2% in Q4. Diagnostics grew 6%, below expectations, while China grew 9%, driven by pharma and biotech. The company faces inflationary pressures but expects mid-teens growth in specialty CDMO. Management reaffirmed a $1 billion reshoring opportunity by 2030. Margins are expected to expand over 100 basis points ex-tariff refunds.

$AHighAI 8/10

Agilent Q3 earnings beat sends shares to 20-day high

Agilent Technologies reported Q3 revenue of $1.88bn, beating guidance and lifting shares to a 20-day high. Operating margin was 27.2%, with EPS of $1.56. Pharma revenue rose 12%, and China sales grew 9%. The company raised its full-year revenue growth outlook to 5.8% to 6%.

$NVDAHighAI 8/10

Stocks making the biggest moves after hours: Nvidia, Salesforce, CrowdStrike, Urban Outfitters and more

Nvidia, Salesforce, Okta, Agilent, CrowdStrike, Everpure, Veeva, Urban Outfitters, and Synopsys reported earnings. Nvidia, Salesforce, Okta, Agilent, CrowdStrike, Everpure, and Veeva exceeded expectations, while Urban Outfitters met estimates and Synopsys fell. Nvidia reported $2.22 EPS and $96.22B revenue, raising Q3 guidance to $108B. Salesforce reported $11.35B revenue and $5.90 EPS. Okta raised full-year guidance. Synopsys raised annual revenue and profit forecasts but shares fell 2%.